title: Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases?
authors.affiliation: Gastroenterology Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
authors.forename: Raffaele
authors.initials: R
authors.lastname: Licinio
authors.affiliation: Gastroenterology Unit, Department of Medical Sciences, University of Foggia, Foggia, Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: Facciorusso
authors.affiliation: Gastroenterology Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
authors.forename: Nicola Maurizio
authors.initials: NM
authors.lastname: Castellaneta
authors.affiliation: Gastroenterology Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
authors.forename: Alfredo
authors.initials: A
authors.lastname: Di Leo
mesh_terms: D001629:Bezafibrate; D050171:Dyslipidemias / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy*; D008297:Male; D063806:Myalgia; D051437:Renal Insufficiency; D014580:Ursodeoxycholic Acid
chemical_list: D014580:Ursodeoxycholic Acid; D001629:Bezafibrate